BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 36500212)

  • 21. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin proteasome system in immune regulation and therapeutics.
    Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
    Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E3-ligase knock down revealed differential titin degradation by autopagy and the ubiquitin proteasome system.
    Müller E; Salcan S; Bongardt S; Barbosa DM; Krüger M; Kötter S
    Sci Rep; 2021 Oct; 11(1):21134. PubMed ID: 34702928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E3 ligase ligand chemistries: from building blocks to protein degraders.
    Sosič I; Bricelj A; Steinebach C
    Chem Soc Rev; 2022 May; 51(9):3487-3534. PubMed ID: 35393989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in PROTACs for Drug Targeted Protein Research.
    Yao T; Xiao H; Wang H; Xu X
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.
    Xi M; Chen Y; Yang H; Xu H; Du K; Wu C; Xu Y; Deng L; Luo X; Yu L; Wu Y; Gao X; Cai T; Chen B; Shen R; Sun H
    Eur J Med Chem; 2019 Jul; 174():159-180. PubMed ID: 31035238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Protein Degradation through E2 Recruitment.
    Forte N; Dovala D; Hesse MJ; McKenna JM; Tallarico JA; Schirle M; Nomura DK
    ACS Chem Biol; 2023 Apr; 18(4):897-904. PubMed ID: 36940189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of E3 Ligase Ligands for Target Protein Degradation.
    Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation.
    Márquez-Cantudo L; Ramos A; Coderch C; de Pascual-Teresa B
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.
    Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y
    Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perilous journey: a tour of the ubiquitin-proteasome system.
    Kleiger G; Mayor T
    Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. F-box protein Fbxo3 targets Smurf1 ubiquitin ligase for ubiquitination and degradation.
    Li D; Xie P; Zhao F; Shu J; Li L; Zhan Y; Zhang L
    Biochem Biophys Res Commun; 2015 Mar; 458(4):941-5. PubMed ID: 25721664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding PROTACtable genome universe of E3 ligases.
    Liu Y; Yang J; Wang T; Luo M; Chen Y; Chen C; Ronai Z; Zhou Y; Ruppin E; Han L
    Nat Commun; 2023 Oct; 14(1):6509. PubMed ID: 37845222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Branched ubiquitin code: from basic biology to targeted protein degradation.
    Ohtake F
    J Biochem; 2022 Mar; 171(4):361-366. PubMed ID: 35037035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
    Thompson JW; Nagel J; Hoving S; Gerrits B; Bauer A; Thomas JR; Kirschner MW; Schirle M; Luchansky SJ
    J Biol Chem; 2014 Oct; 289(42):28942-55. PubMed ID: 25147182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
    Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
    Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing the Effects of SIAH Ubiquitin E3 Ligases on Lysine Acetyl Transferases.
    Hagenbucher J; Stekman H; Rodriguez-Gil A; Kracht M; Schmitz ML
    Methods Mol Biol; 2017; 1510():297-312. PubMed ID: 27761830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.